Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Leyssen

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
EMBO Reports|January 5, 2007
A fruitfly's guide to keeping the brain wiredMaarten Leyssen, Bassem A Hassan
Vaccine|April 24, 2016
Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccineJiri Beran, Olivier Van Der Meeren, Maarten Leyssen, et al.
Neuroscience Letters|May 22, 2003
The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosisPhilip Van Damme, Maarten Leyssen, Geert Callewaert, et al.
The Pediatric Infectious Disease Journal|July 11, 2013
A randomized, controlled trial to assess the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, hib and meningococcal serogroup C combination vaccine administered at 2, 3, 4 and 12-18 months of ageLeszek Szenborn, Hanna Czajka, Jerzy Brzostek, et al.
Human Vaccines|June 5, 2010
Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adultsJirí Beran, Lenka Hobzova, Veronika Wertzova, et al.
Journal of Medical Virology|August 22, 2009
Long-term immunogenicity of preservative-free hepatitis B vaccine formulations in adultsPierre Van Damme, Frank von Sonnenburg, Christoph Hatz, et al.
The Pediatric Infectious Disease Journal|February 25, 2011
Long-term immunogenicity and immune memory after two doses of the adult formulation of a combined hepatitis A and B vaccine in children 1 to 11 years of agePierre van Damme, Froukje Kafeja, Marie Van Der Wielen, et al.
Vaccine|November 7, 2009
Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in ThailandYong Poovorawan, Voranush Chongsrisawat, Apiradee Theamboonlers, et al.
The EMBO Journal|July 30, 2005
Amyloid precursor protein promotes post-developmental neurite arborization in the Drosophila brainMaarten Leyssen, Derya Ayaz, Sébastien S Hébert, et al.
The Pediatric Infectious Disease Journal|July 19, 2014
A randomized study to evaluate the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, haemophilus influenzae b, and meningococcal serogroup C combination vaccine administered to infants at 2, 4 and 12 months of ageFranck Thollot, David Scheifele, Heidemarie Pankow-Culot, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
EMBO Reports|January 5, 2007
A fruitfly's guide to keeping the brain wiredMaarten Leyssen, Bassem A Hassan
Vaccine|April 24, 2016
Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccineJiri Beran, Olivier Van Der Meeren, Maarten Leyssen, et al.
Neuroscience Letters|May 22, 2003
The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosisPhilip Van Damme, Maarten Leyssen, Geert Callewaert, et al.
The Pediatric Infectious Disease Journal|July 11, 2013
A randomized, controlled trial to assess the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, hib and meningococcal serogroup C combination vaccine administered at 2, 3, 4 and 12-18 months of ageLeszek Szenborn, Hanna Czajka, Jerzy Brzostek, et al.
Human Vaccines|June 5, 2010
Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adultsJirí Beran, Lenka Hobzova, Veronika Wertzova, et al.
Journal of Medical Virology|August 22, 2009
Long-term immunogenicity of preservative-free hepatitis B vaccine formulations in adultsPierre Van Damme, Frank von Sonnenburg, Christoph Hatz, et al.
The Pediatric Infectious Disease Journal|February 25, 2011
Long-term immunogenicity and immune memory after two doses of the adult formulation of a combined hepatitis A and B vaccine in children 1 to 11 years of agePierre van Damme, Froukje Kafeja, Marie Van Der Wielen, et al.
Vaccine|November 7, 2009
Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in ThailandYong Poovorawan, Voranush Chongsrisawat, Apiradee Theamboonlers, et al.
The EMBO Journal|July 30, 2005
Amyloid precursor protein promotes post-developmental neurite arborization in the Drosophila brainMaarten Leyssen, Derya Ayaz, Sébastien S Hébert, et al.
The Pediatric Infectious Disease Journal|July 19, 2014
A randomized study to evaluate the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, haemophilus influenzae b, and meningococcal serogroup C combination vaccine administered to infants at 2, 4 and 12 months of ageFranck Thollot, David Scheifele, Heidemarie Pankow-Culot, et al.
Pageof 4